Crossmark

NMR-filtered virtual screening leads to non-metal chelating metallo-β-lactamase inhibitors

Crossref DOI link: https://doi.org/10.1039/C6SC04524C

Published Online: 2017

Update policy: https://doi.org/10.1039/rsc_crossmark_policy

Authors

Li, Guo-Bo

Abboud, Martine I. https://orcid.org/0000-0003-2141-5988
Brem, Jürgen

Someya, Hidenori

Lohans, Christopher T.

Yang, Sheng-Yong

Spencer, James

Wareham, David W.

McDonough, Michael A. https://orcid.org/0000-0003-4664-6942
Schofield, Christopher J. https://orcid.org/0000-0002-0290-6565
Funding

Funding for this research was provided by:

Wellcome Trust

Medical Research Council (G1100135, MR/L007665/1, SWON Alliance)

China Postdoctoral Science Foundation (2015M570789)

National Natural Science Foundation of China (81502989)
More Information

SIMILARITY CHECK

: This document is Similarity Check deposited

RELATED DATA

: Supplementary Information

IDENTIFIERS

: Martine I. Abboud (ORCID)

: Michael A. McDonough (ORCID)

: Christopher J. Schofield (ORCID)

COPYRIGHT AND LICENSING

: The Royal Society of Chemistry has an exclusive publication licence for this journal

OPEN ACCESS: This article is freely available. This article is licensed under a Creative Commons Attribution 3.0 Unported Licence (CC BY 3.0)

PEER REVIEW METHOD

: Single-blind

PUBLICATION HISTORY

: Received 10 October 2016; Accepted 13 December 2016; Accepted Manuscript published 14 December 2016; Advance Article published 22 December 2016; Version of Record published 30 January 2017